Literature DB >> 28927149

MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer.

Jia Cao1, Xiu-Rui Yan2, Ting Liu2, Xue-Bo Han1, Jing-Jing Yu2,3, Shi-Hai Liu4, Li-Bin Wang1,2,3.   

Abstract

The purpose of the present study was to analyze the crucial role of microRNAs (miRNAs/miRs) involved in the proliferation and migration of colorectal cancer (CRC) and to investigate their underlying mechanisms. The present study discusses the expression and function of miR-552 in CRC. The expression level of miR-552 in CRC cells and tissues was observed, and it was suggested that the high expression of miR-552 accelerated the proliferation and migration of CRC cells in vitro. Notably, a result of the present study was that the cell fate determination factor Dachshund family transcription factor 1 (DACH1) was identified as a direct target of miR-552. Suppressing miR-552 expression in CRC cells increased endogenous DACH1 mRNA and protein levels, which was negatively correlated with miR-552. DACH1 performs an important role in the development of a number of neoplasms, and has the ability to regulate the Wnt/β-catenin signaling pathway as a novel predictive and diagnostic biomarker. Accordingly, it was concluded that miR-552 exerted a tumor-promoting role in CRC development by targeting DACH1, which may contribute to the increase in the rates of CRC proliferation and migration. miR-552 may serve as a potential diagnostic and prognostic biomarker for CRC.

Entities:  

Keywords:  colorectal cancer; dachshund family transcription factor 1; microRNA-552; migration; proliferation

Year:  2017        PMID: 28927149      PMCID: PMC5588050          DOI: 10.3892/ol.2017.6600

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression.

Authors:  Raheleh Amirkhah; Ulf Schmitz; Michael Linnebacher; Olaf Wolkenhauer; Ali Farazmand
Journal:  Genes Chromosomes Cancer       Date:  2015-03       Impact factor: 5.006

3.  MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.

Authors:  Rongpan Bai; Chunhua Weng; Haojie Dong; Siqi Li; Guangdi Chen; Zhengping Xu
Journal:  Int J Cancer       Date:  2015-06-04       Impact factor: 7.396

4.  miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung.

Authors:  Hark Kyun Kim; Na Jung Lim; Sang-Geun Jang; Geon Kook Lee
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

5.  Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.

Authors:  Keun Hur; Yuji Toiyama; Yoshinaga Okugawa; Shozo Ide; Hiroki Imaoka; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2015-12-23       Impact factor: 23.059

6.  MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.

Authors:  Zhaoping Qiu; Weijie Guo; Qifeng Wang; Zhiao Chen; Shenglin Huang; Fangyu Zhao; Ming Yao; Yingjun Zhao; Xianghuo He
Journal:  Gastroenterology       Date:  2015-08-03       Impact factor: 22.682

7.  Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.

Authors:  Wenji Yan; Kongming Wu; James G Herman; Malcolm V Brock; François Fuks; Lili Yang; Hongbin Zhu; Yazhuo Li; Yunsheng Yang; Mingzhou Guo
Journal:  Epigenetics       Date:  2013-10-22       Impact factor: 4.528

Review 8.  MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

Authors:  Silvia Giordano; Amedeo Columbano
Journal:  Hepatology       Date:  2012-12-26       Impact factor: 17.425

9.  Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients.

Authors:  Giuseppina Della Vittoria Scarpati; Enrica Calura; Mariacristina Di Marino; Chiara Romualdi; Luca Beltrame; Umberto Malapelle; Giancarlo Troncone; Alfonso De Stefano; Stefano Pepe; Sabino De Placido; Maurizio D'Incalci; Sergio Marchini; Chiara Carlomagno
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  22 in total

1.  miR-552 promotes laryngocarcinoma cells proliferation and metastasis by targeting p53 pathway.

Authors:  Jia Gu; Tao Han; Lei Sun; Ai-Hui Yan; Xue-Jun Jiang
Journal:  Cell Cycle       Date:  2020-04-01       Impact factor: 4.534

2.  Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.

Authors:  Johann Ebadfardzadeh; Mandana Kazemi; Ali Aghazadeh; Monireh Rezaei; Milad Shirvaliloo; Roghayeh Sheervalilou
Journal:  Med Oncol       Date:  2021-08-14       Impact factor: 3.064

Review 3.  MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials.

Authors:  Faeze Ahmadi Beni; Mohammad Kazemi; Hassan Dianat-Moghadam; Mohadeseh Behjati
Journal:  Funct Integr Genomics       Date:  2022-10-20       Impact factor: 3.674

4.  MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).

Authors:  Feng Tong; Youhua Ying; Haihua Pan; Wei Zhao; Hongchen Li; Xiaoli Zhan
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

5.  Circular RNA SMARCA5 functions as an anti-tumor candidate in colon cancer by sponging microRNA-552.

Authors:  Shiwei Yang; Shanyu Gao; Tongming Liu; Junning Liu; Xia Zheng; Zhi Li
Journal:  Cell Cycle       Date:  2021-03-22       Impact factor: 4.534

6.  Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.

Authors:  Ronja S Adam; Dennis Poel; Leandro Ferreira Moreno; Joey M A Spronck; Tim R de Back; Arezo Torang; Patricia M Gomez Barila; Sanne Ten Hoorn; Florian Markowetz; Xin Wang; Henk M W Verheul; Tineke E Buffart; Louis Vermeulen
Journal:  Mol Oncol       Date:  2022-04-29       Impact factor: 7.449

Review 7.  Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).

Authors:  Taxiarchis Konstantinos Nikolouzakis; Loukia Vassilopoulou; Persefoni Fragkiadaki; Theodoros Mariolis Sapsakos; Georgios Z Papadakis; Demetrios A Spandidos; Aristides M Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2018-03-21       Impact factor: 4.136

8.  DACH1 inhibits glioma invasion and tumor growth via the Wnt/catenin pathway.

Authors:  Jing Wang; Yan Zou; Xuechao Wu; Mu Chen; Shuai Zhang; Xiaojie Lu; Qing Wang
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147

9.  Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.

Authors:  Chun-Hui Lai; Xu-Zhi Liang; Xiu-Yun Liang; Sheng-Jun Ma; Jun-Guo Li; Ming-Fang Shi; Xu Zhu; Hui-Hua Lan; Jiang-Hui Zeng
Journal:  Biomed Res Int       Date:  2019-10-15       Impact factor: 3.411

10.  MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.

Authors:  Weiqing Qu; Xinyuan Wen; Keli Su; Wei Gou
Journal:  J Cell Mol Med       Date:  2018-12-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.